BioCentury
ARTICLE | Clinical News

Inactivated H1N1 vaccine: Phase II started

September 7, 2009 7:00 AM UTC

Researchers began a double-blind, U.S. Phase II trial to evaluate 2 doses of either 3.75, 7.5 or 15 µg of sanofi's intramuscular swine influenza A (H1N1) vaccine given 3 weeks apart with or without AS...